Laboratoire Aron

Laboratoire Aron was a prominent French pharmaceutical company founded in the mid-20th century, specializing in the development of neuropsychiatric and cardiovascular medications. The company is best known for developing amineptine (Survector), a dopamine reuptake inhibitor used as an antidepressant. In 1983, the company was acquired by Synthelabo, which subsequently merged with Sanofi. Today, the legacy of Laboratoire Aron exists within the broader portfolio of Sanofi, having contributed significantly to the French pharmaceutical landscape during its period of independence. The company was a key player in the mid-century expansion of the French life sciences sector, focusing on innovative small molecule therapies.